image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Plus500 - Shares surge towards £15

October 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 1459p
Plus500, the leading technology platform for trading CFDs, announced blockbuster interim results, sending the shares soaring above £15.Covid-19 related volatility in the markets has helped drive an amazing 281% increase in revenues to US$564m (derived from customer spreads and overnight charges) with EBITDA growing 452% to US$361.8m. Earnings per share rose from 45 cents to 298 cents. The scalability of its platform (spreading rising revenues over a relatively fixed cost base) saw EBITDA margins spike violently from 44% to 64%! Profitability was also boosted by a 41% reduction in customer acquisition costs from US$1,079 to US$634.With market leadership strengthened in key regions such as UK, Germany and Spain, the number of a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe